You are reading the report for 2026-10-05. The figures are as they stood that day and are not revised. See the current report →

Daily Special Report

Published Oct 6

The Street Split Watch List

Where the analysts disagree

4 companiesData through Oct 5

The widest disagreement is between CRML at +177% and PTC at +6%, the two ends of the target-versus-price range among the companies shown here. Those percentages compare the most recent target with the price at the time it was set, rather than a common live price. The up/down counts and disclosed bands keep the focus on how the views differ, not on a recommendation.

Gap between the latest price target and the current priceTARGET VS CURRENT PRICE · PUBLISHED RANGERXOno published targetPTC+6% $205 – $306EXE+41% $120 – $141CRML+177%

Entry by entry — why each one is on the board

RXORXO, Inc.
Split1 up / 1 down
Target vs price—
Range—

RXO has 1 up / 1 down, the smallest split of the 2 here. The gap between target and price is —, the only one here with that gap.

split: 1 up, 1 down · Cowen & Co., Jefferies

PTCPTC Inc.
Split0 up / 4 down
Target vs price+6%
Range$205 – $306

PTC has 0 up / 4 down, the biggest split of the 2 here. Its targets span $205 – $306, the biggest disclosed band of the 2 here.

targets $205-$306 · Barclays, Deutsche Bank, KeyBanc

EXEExpand Energy Corporation
Split—
Target vs price+41%
Range$120 – $141

By contrast, EXE shows +41% between target and price, the second-largest gap between target and price of the 3 here. Its disclosed band is $120 – $141, the smallest disclosed band of the 2 here.

targets $120-$141 · Raymond James, Truist Financial

CRMLCritical Metals Corp.
Split—
Target vs price+177%
Range—

Meanwhile, CRML shows +177% between target and price, the biggest gap between target and price of the 3 here. Its disclosed band is —, matching RXO's.

UBS

How this board was built

Grade changes and price targets published in the latest analyst feed. “Target vs price” compares the most recent target with the price at the time it was set. Analyst opinion is not a recommendation.